Clinical Trials Logo

Clinical Trial Summary

This protocol is part of an FDA Individual Patient Expanded Access IND. This study is to be conducted according to US and International Standards of Good Clinical Practice (FDA Title 21 part 312 and International Conference on Harmonization guidelines), applicable government regulations and Hope Biosciences Stem Cell Research Foundation policies and procedures.


Clinical Trial Description

This Individual Patient Expanded Access IND has been created per the request of a 65-year-old woman diagnosed with Systemic Lupus Erythematosus (SLE). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04907175
Study type Expanded Access
Source Hope Biosciences
Contact
Status No longer available
Phase

See also
  Status Clinical Trial Phase
Recruiting NCT04024306 - Steroid-induced Diabetes Mellitus in Systemic Lupus Erythematosus (SLE) Patients
Active, not recruiting NCT04018222 - Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
Completed NCT04527172 - Neuromuscular Ultrasonography Utility for Detection of Peripheral Neuropathy in Systemic Lupus Erythematosus
Completed NCT05458531 - Monitoring of Inflammatory Conditions
Completed NCT04970199 - Cardiovascular Protective Role of Laser Acupuncture in Systemic Lupus N/A
Completed NCT03426384 - FLARE Lupus Research Study Systemic Lupus Erythematosus N/A
Recruiting NCT05984316 - Systemic Lupus Erythematosus N/A
Completed NCT03171194 - Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus Phase 1
Recruiting NCT06383104 - Myofascial Techniques and Proprioceptive Neuromuscular Facilitation in Patients With Systemic Lupus Erythematosus. N/A
Not yet recruiting NCT05314881 - NCF Gene & TNFSF4 in SLE Patients N/A